Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Wellbeing Digital Sciences Inc KONEF

Healthcare Psychedelics
Wellbeing Digital Sciences Inc. is an evidence-based mental healthcare company. The Company is focused on the development and implementation of clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. It operates through three segments: Wellbeing & IRP; KGK Science and Mindscape. It operates medical clinics across North America to help its patients access plant-based medicines, psychedelics, and other forms of mental health care, all of which have the potential to heal them of their physical and/or emotional pain. Its subsidiaries include Mindscape Ketamine & Infusions Therapy LLC, KGK Science Inc. and Integrated Rehab and Performance Ltd. It is supported by a network of North American clinics that provide therapies and other types of treatment to patients, as well as through a contract research organization that offers clinical trials services to clients pursuing drug development.


GREY:KONEF - Post by User

Wellbeing Digital Sciences Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(26)
•••
Post by XeniaTechieon Jul 07, 2021 4:06pm
75 Views
Post# 33506749

Why KetamineOne ($MEDI) is ONE to watch

Why KetamineOne ($MEDI) is ONE to watchKetamineOne ($MEDI) is a serious one to watch - currently operating 16 clinics across N.C with a target expansion of 30, $3.5M revenue in F2020 and $6M expected for 2021. More information is available on their website, https://www.ketamine.one/investor-relations
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities